| 摘要 |
<p>The present invention relates to compounds or pharmaceutically acceptable salts thereof, to processes for their preparation, to pharmaceutical compositions containing them, and to the use of such compounds in therapeutical use. In particular, the compounds are inhibitors of metalloproteinases involved in tissue degradation and various physiological and pathophysiological processes.</p> |
